Loading...
Docoh

Meridian Bioscience (VIVO)

Meridian Bioscience Inc. is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.The company is dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, Meridian provides critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, Meridian provides diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. The company builds relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

Company profile

Ticker
VIVO
Exchange
CEO
John Kenny
Employees
Incorporated
Location
Fiscal year end
Former names
MERIDIAN DIAGNOSTICS INC
SEC CIK
Subsidiaries
Meridian Bioscience Corporation • Meridian Life Science, Inc. • Meridian Bioscience Europe, s.r.l. • Meridian Bioscience Europe S.A. • Meridian Bioscience Europe B.V. • Meridian Bioscience UK Ltd. • Meridian Bioscience International Ltd. • Meridian Bioscience Beijing, LLC • Meridian Bioscience Canada, Inc. • Meridian Bioscience Israel Holding Ltd ...
IRS number
310888197

VIVO stock data

Analyst ratings and price targets

Last 3 months

Calendar

5 Aug 22
12 Aug 22
30 Sep 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Sep 21 Sep 20 Sep 19 Sep 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 83.49M 83.49M 83.49M 83.49M 83.49M 83.49M
Cash burn (monthly) (no burn) (no burn) 2.23M (no burn) (no burn) (no burn)
Cash used (since last report) n/a n/a 3.22M n/a n/a n/a
Cash remaining n/a n/a 80.26M n/a n/a n/a
Runway (months of cash) n/a n/a 36.0 n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
27 Jun 22 Kenny John P. Common Stock Sell Dispose S No Yes 30.3854 61,437 1.87M 265,131
27 Jun 22 Kenny John P. Common Stock Option exercise Acquire M No No 10.1 61,437 620.51K 326,568
27 Jun 22 Kenny John P. Stock Options Common Stock Option exercise Dispose M No Yes 10.1 61,437 620.51K 66,039
24 Jun 22 Kenny John P. Common Stock Sell Dispose S No Yes 30.0049 13,559 406.84K 265,131
24 Jun 22 Kenny John P. Common Stock Option exercise Acquire M No No 10.1 13,559 136.95K 278,690
24 Jun 22 Kenny John P. Stock Options Common Stock Option exercise Dispose M No Yes 10.1 13,559 136.95K 127,476
23 Jun 22 Kenny John P. Common Stock Sell Dispose S No Yes 29.9764 19,956 598.21K 265,131
23 Jun 22 Kenny John P. Common Stock Option exercise Acquire M No No 10.1 14,607 147.53K 285,087
23 Jun 22 Kenny John P. Common Stock Option exercise Acquire M No No 14.5 5,349 77.56K 270,480
23 Jun 22 Kenny John P. Stock Options Common Stock Option exercise Dispose M No Yes 10.1 14,607 147.53K 141,035
13F holders Current Prev Q Change
Total holders 209 182 +14.8%
Opened positions 44 28 +57.1%
Closed positions 17 27 -37.0%
Increased positions 61 49 +24.5%
Reduced positions 68 68
13F shares Current Prev Q Change
Total value 1.14B 860.86M +32.2%
Total shares 44.09M 42.2M +4.5%
Total puts 56.1K 149.6K -62.5%
Total calls 194.1K 226.6K -14.3%
Total put/call ratio 0.3 0.7 -56.2%
Largest owners Shares Value Change
BLK Blackrock 7.37M $191.3M -0.5%
Vanguard 4.79M $124.39M -1.8%
Impactive Capital 4.32M $112.2M +1269.6%
Earnest Partners 3.66M $94.93M -1.8%
Royce & Associates 2.02M $52.37M -8.1%
Dimensional Fund Advisors 1.91M $49.46M +1.0%
Renaissance Technologies 1.83M $47.63M -4.1%
STT State Street 1.66M $43.01M -4.6%
Kempen Capital Management 1.54M $40.09M +12.8%
Flynn James E 1.13M $22.95M 0.0%
Largest transactions Shares Bought/sold Change
Impactive Capital 4.32M +4.01M +1269.6%
Deerfield Management 0 -1.13M EXIT
Acuitas Investments 0 -330.37K EXIT
Clark Estates 0 -220K EXIT
LSV Asset Management 199.34K -212.94K -51.6%
Fort Washington Investment Advisors 640.42K +197.55K +44.6%
Royce & Associates 2.02M -178.48K -8.1%
Kempen Capital Management 1.54M +174.91K +12.8%
Nuveen Asset Management 248.09K -135.57K -35.3%
Massachusetts Financial Services 10.24K -95.95K -90.4%

Financial report summary

?
Management Discussion
  • A net loss of $7,338, or $0.16 per diluted share, was generated during the third quarter of fiscal 2022, compared to $11,669 of net earnings, or $0.26 per diluted share, during the third quarter of fiscal 2021. The net loss in the third quarter of fiscal 2022 reflects primarily the overall increase in operating expenses described in the Operating Expenses section below, along with the decline in net revenues and operating income in our Life Science segment, stemming from the softening in demand forCOVID-19
  • COVID-19.
  • COVID-19.

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: absence, agree, analyst, Antitrust, apreliminary, attached, attract, automatically, Bioscensor, Biosensor, brought, cancelled, cease, Comprehensive, confidence, contemplated, customary, Delaware, deny, dissenting, diversion, entirety, entitled, equal, Euro, exhibit, fee, foregoing, investor, iv, Korea, LLC, Madeira, merge, Merger, month, movement, organized, outlook, outpaced, par, Parent, pending, proposed, purport, qualified, Republic, retain, satisfaction, SD, SDB, shareholder, SJL, stockholder, surviving, timeframe, transportation
Removed: base, begun, careful, deem, facing, fourth, hold, returned